Thus, we investigated whether inhibition of TOP1 degradation using NEDD8-activating enzyme inhibitor MLN4924 could result in better anti-tumor effects of 10-HCPT in HNSCC treatment. The gene discussed is TOP1; the disease is head and neck squamous cell carcinoma.